Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $11.14B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,777,777 | $1.505B | 13.5% | — | — | Common | 91307C102 |
| ASND | ASCENDIS PHARMA | 5,111,111 | $1.363B | 12.2% | — | — | ORDINARY SHARES | K08588103 |
| KRYS | KRYSTAL BIOTECH INC | 2,888,888 | $1.074B | 9.6% | — | — | Common | 501147102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,833,333 | $984M | 8.8% | — | — | Common | 558868105 |
| ARGX | ARGENX SE | 1,000,000 | $928M | 8.3% | — | — | Sponsored ADR | 04016X101 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 11,355,555 | $926M | 8.3% | — | — | Common | 04280A100 |
| KYMR | KYMERA THERAPEUTICS INC | 7,474,747 | $857M | 7.7% | — | — | Common | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 2,297,000 | $430M | 3.9% | — | — | Common | 76155X100 |
| CYTK | CYTOKINETICS INC | 4,999,999 | $426M | 3.8% | — | — | Common | 23282W605 |
| CELC | CELCUITY INC | 3,400,000 | $356M | 3.2% | — | — | Common | 15102K100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 6,555,555 | $352M | 3.2% | — | — | SPONSORED ADS | 86366E106 |
| XENE | XENON PHARMACEUTICALS INC | 5,777,777 | $349M | 3.1% | — | — | Common | 98420N105 |
| DFTX | DEFINIUM THERAPEUTICS INC | 7,188,888 | $338M | 3.0% | — | — | Common | 24477V105 |
| QURE | UNIQURE NV | 6,727,777 | $310M | 2.8% | — | — | Common | N90064101 |
| VERA | VERA THERAPEUTICS INC | 5,723,888 | $246M | 2.2% | — | — | Common | 92337R101 |
| TSHA | TAYSHA GENE THERAPIES INC | 23,888,888 | $163M | 1.5% | — | — | Common | 877619106 |
| OCUL | OCULAR THERAPEUTIX INC | 12,540,000 | $123M | 1.1% | — | — | Common | 67576A100 |
| GLTO | DAMORA THERAPEUTICS INC | 3,783,000 | $98.4M | 0.9% | — | — | Common | 36322Q206 |
| COAG | HEMAB THERAPEUTICS HLDGS INC | 1,925,150 | $70.71M | 0.6% | — | — | Common | 423494103 |
| GHRS | GH RESEARCH PLC | 1,800,000 | $48.38M | 0.4% | — | — | ORDINARY SHARES | G3855L106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,500,000 | $45.92M | 0.4% | — | — | Common | 92790C104 |
| SEPN | SEPTERNA INC | 1,337,500 | $44.79M | 0.4% | — | — | Common | 81734D104 |
| AVTX | AVALO THERAPEUTICS | 2,333,333 | $43.12M | 0.4% | — | — | Common | 05338F306 |
| SNSE | FAETH THERAPEUTICS INC | 1,444,039 | $36.1M | 0.3% | — | — | COMMON | 81728A207 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 2,849,402 | $13.05M | 0.1% | — | — | Common | 00032Q104 |
| LXEO | LEXEO THERAPEUTICS INC | 1,489,189 | $6.932M | 0.1% | — | — | Common | 52886X107 |